Health Services

Dáil Éireann Debate, Tuesday - 27 January 2026

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 27 January 2026

Questions (1078)

David Cullinane

Question:

1078. Deputy David Cullinane asked the Minister for Health if she has given consideration to providing drug payment scheme cover for GLP-1 receptor agonists and similar for metabolic management for PCOS and similar endocrine conditions; and if she will make a statement on the matter. [6250/26]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer